Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2017, Article ID 1403054, 6 pages
https://doi.org/10.1155/2017/1403054
Research Article

The Immunoexpression of Glucocorticoid Receptors in Breast Carcinomas, Lactational Change, and Normal Breast Epithelium and Its Possible Role in Mammary Carcinogenesis

1Department of Pathology, Salmaniya Medical Complex and Royal College of Surgeons in Ireland, Manama, Bahrain
2Department of Pathology, Southend University Hospital, Prittlewell Chase, Westcliff-on-Sea, Essex SS0 0RY, UK
3Department of Pathology, Arabian Gulf University, Manama, Bahrain
4Fakhro Medical City, Manama, Bahrain
5Department of Molecular Medicine, Arabian Gulf University, Manama, Bahrain

Correspondence should be addressed to Raja Alyusuf; hb.vog.htlaeh@fisuoyr

Received 4 June 2017; Revised 20 August 2017; Accepted 15 October 2017; Published 19 November 2017

Academic Editor: Stephen R. Grobmyer

Copyright © 2017 Raja Alyusuf et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. D. Conzen, “Nuclear receptors and breast cancer,” Molecular Endocrinology, vol. 22, no. 10, pp. 2215–2228, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. C. Allegra, M. E. Lippman, E. B. Thompson et al., “Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer,” Cancer research, vol. 39, no. 5, pp. 1447–1454, 1979. View at Google Scholar
  3. H.-C. Lien, Y.-S. Lu, A.-L. Cheng et al., “Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms,” The Journal of Pathology, vol. 209, no. 3, pp. 317–327, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. J. S. Vaidya, G. Baldassarre, M. A. Thorat, and S. Massarut, “Role of glucocorticoids in breast cancer,” Current Pharmaceutical Design, vol. 16, no. 32, pp. 3593–3600, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. R. Oakes, H. N. Hilton, and C. J. Ormandy, “Key stages in mammary gland development: The alveolar switch: Coordinating the proliferative cues and cell fate decisions that drive the formation of lobuloalveoli from ductal epithelium,” Breast Cancer Research, vol. 8, no. 2, article no. 207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. J. Naylor, S. R. Oakes, M. Gardiner-Garden et al., “Transcriptional changes underlying the secretory activation phase of mammary gland development,” Molecular Endocrinology, vol. 19, no. 7, pp. 1868–1883, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Liu, G. W. Robinson, K. Wagner, L. Garrett, A. Wynshaw-Boris, and L. Hennighausen, “Stat5a is mandatory for adult mammary gland development and lactogenesis,” Genes & Development, vol. 11, no. 2, pp. 179–186, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. M. C. Neville, T. B. McFadden, and I. Forsyth, “Hormonal regulation of mammary differentiation and milk secretion,” Journal of Mammary Gland Biology and Neoplasia, vol. 7, no. 1, pp. 49–66, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Russo and I. H. Russo, “Toward a Physiological Approach to Breast Cancer Prevention,” Cancer Epidemiology, Biomarkers & Prevention, vol. 3, no. 4, pp. 353–364, 1994. View at Google Scholar · View at Scopus
  10. R. H. Alyusuf, J. A. Matouq, S. Taha, and J. F. Wazir, “The pattern of expression and role of triiodothyronine (T3) receptors and type i 5-deiodinase in breast carcinomas, benign breast diseases, lactational change, and normal breast epithelium,” Applied Immunohistochemistry & Molecular Morphology , vol. 22, no. 7, pp. 518–523, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. J. C. L. Leo, C. Guo, C. T. Woon, S. E. Aw, and V. C. L. Lin, “Glucocorticoid and Mineralocorticoid Cross-Talk with Progesterone Receptor to Induce Focal Adhesion and Growth Inhibition in Breast Cancer Cells,” Endocrinology, vol. 145, no. 3, pp. 1314–1321, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. T. M. Wintermantel, D. Bock, V. Fleig, E. F. Greiner, and G. Schütz, “The epithelial glucocorticoid receptor is required for the normal timing of cell proliferation during mammary lobuloalveolar development but is dispensable for milk production,” Molecular Endocrinology, vol. 19, no. 2, pp. 340–349, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Wu, S. Chaudhuri, D. R. Brickley, D. Pang, T. Karrison, and S. D. Conzen, “Microarray Analysis Reveals Glucocorticoid-Regulated Survival Genes That Are Associated with Inhibition of Apoptosis in Breast Epithelial Cells,” Cancer Research, vol. 64, no. 5, pp. 1757–1764, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. T. J. Moran, S. Gray, C. A. Mikosz, and S. D. Conzen, “The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells,” Cancer Research, vol. 60, no. 4, pp. 867–872, 2000. View at Google Scholar · View at Scopus
  15. W. Wu, M. Zou, D. R. Brickley, T. Pew, and S. D. Conzen, “Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells,” Molecular Endocrinology, vol. 20, no. 10, pp. 2304–2314, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. J. Nass and N. E. Davidson, “The biology of breast cancer,” Hematology/Oncology Clinics of North America, vol. 13, no. 2, pp. 311–332, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Sahoo, D. R. Brickley, M. Kocherginsky, and S. D. Conzen, “Coordinate expression of the PI3-kinase downstream effectors serum and glucocorticoid-induced kinase (SGK-1) and Akt-1 in human breast cancer,” European Journal of Cancer, vol. 41, no. 17, pp. 2754–2759, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Gong, M. J. Jarzynka, T. J. Cole et al., “Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase,” Cancer Research, vol. 68, no. 18, pp. 7386–7393, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Vilasco, L. Communal, N. Mourra, A. Courtin, P. Forgez, and A. Gompel, “Glucocorticoid receptor and breast cancer,” Breast Cancer Research and Treatment, vol. 130, no. 1, pp. 1–10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. P. A. Volden and S. D. Conzen, “The influence of glucocorticoid signaling on tumor progression,” Brain, Behavior, and Immunity, vol. 30, pp. S26–S31, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Reeder, M. Attar, L. Nazario et al., “Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage,” British Journal of Cancer, vol. 112, no. 9, pp. 1461–1470, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Wu, T. Pew, M. Zou, D. Pang, and S. D. Conzen, “Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival,” The Journal of Biological Chemistry, vol. 280, no. 6, pp. 4117–4124, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Moutsatsou and A. G. Papavassiliou, “The glucocorticoid receptor signalling in breast cancer: Breast Carcinoma,” Journal of Cellular and Molecular Medicine, vol. 12, no. 1, pp. 145–163, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Ling and R. Kumar, “Crosstalk between NFkB and glucocorticoid signaling: A potential target of breast cancer therapy,” Cancer Letters, vol. 322, no. 2, pp. 119–126, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Conde, R. Paniagua, B. Fraile, J. Lucio, and M. I. Arenas, “Glucocorticoid receptor changes its cellular location with breast cancer development,” Histology and Histopathology, vol. 23, no. 1, pp. 77–85, 2008. View at Google Scholar · View at Scopus
  26. T. M. Regan Anderson, S. H. Ma, G. V. Raj et al., “Breast tumor kinase (Brk/PTK6) is induced by HIF, glucocorticoid receptor, and PELP1-mediated stress signaling in triple-negative breast cancer,” Cancer Research, vol. 76, no. 6, pp. 1653–1663, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. M. N. Skor, E. L. Wonder, M. Kocherginsky et al., “Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer,” Clinical Cancer Research, vol. 19, no. 22, pp. 6163–6172, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. Chen, X. Lan, D. Wu et al., “Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer,” Nature Communications, vol. 6, article no. 8323, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Buxant, C. Engohan-Aloghe, and J.-C. Noël, “Estrogen receptor, progesterone receptor, and glucocorticoid receptor expression in normal breast tissue, breast in situ carcinoma, and invasive breast cancer,” Applied Immunohistochemistry & Molecular Morphology , vol. 18, no. 3, pp. 254–257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Pan, M. Kocherginsky, and S. D. Conzen, “Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer,” Cancer Research, vol. 71, no. 20, pp. 6360–6370, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. D. C. West, D. Pan, E. Y. Tonsing-Carter et al., “GR and ER coactivation alters the expression of differentiation genes and associates with improved ER+ breast cancer outcome,” Molecular Cancer Research, vol. 14, no. 8, pp. 707–719, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Abduljabbar, O. H. Negm, C.-F. Lai et al., “Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer,” Breast Cancer Research and Treatment, vol. 150, no. 2, pp. 335–346, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. R. A. Smith, R. A. Lea, S. R. Weinstein, and L. R. Griffiths, “Progesterone, glucocorticoid, but not estrogen receptor mRNA is altered in breast cancer stroma,” Cancer Letters, vol. 255, no. 1, pp. 77–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. R. E. Hall, C. S. L. Lee, I. E. Alexander, J. Shine, C. L. Clarke, and R. L. Sutherland, “Steroid hormone receptor gene expression in human breast cancer cells: Inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels,” International Journal of Cancer, vol. 46, no. 6, pp. 1081–1087, 1990. View at Publisher · View at Google Scholar · View at Scopus
  35. H. K. Kinyamu and T. K. Archer, “Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in Mdm2 protein expression,” Molecular and Cellular Biology, vol. 23, no. 16, pp. 5867–5881, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Zhang, D. Y. M. Leung, S. K. Nordeen, and E. Goleva, “Estrogen inhibits glucocorticoid action via protein phosphatase 5 (PP5)-mediated glucocorticoid receptor dephosphorylation,” The Journal of Biological Chemistry, vol. 284, no. 36, pp. 24542–24552, 2009. View at Publisher · View at Google Scholar · View at Scopus